Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 3:19 PM UTC
| NCT Number | NCT06717347 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | PHASE3 |
| Target Enrollment | 1,046 participants |
| Active Locations | 48 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 28, 2026 (4 days ago) |
As of September 1, 2026: Clinical trial NCT06717347 is currently recruiting participants. This phase3 study for diffuse large b-cell lymphoma is actively seeking new participants at 48 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06717347 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 48 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06717347 was last updated 4 days ago (August 28, 2026). HelloStudys verifies this status automatically.